Laura M. Wanner

A Chemotype That Inhibits Three Unrelated Pathogenic Targets: The Botulinum Neurotoxin Serotype A Light Chain, <i>P. falciparum</i> Malaria, and the Ebola Filovirus

Igor Opsenica, James C. Burnett, Rick Gussio et al. · Journal of Medicinal Chemistry · 2011 · 47 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

Embryonic stem cell-derived motoneurons provide a highly sensitive cell culture model for botulinum neurotoxin studies, with implications for high-throughput drug discovery

Erkan Kiris, Jonathan E. Nuss, James C. Burnett et al. · Stem Cell Research · 2011 · 42 citations · Full text

Life Sciences, Neurobiology, Neuroscience +16

Multi-Faceted Proteomic Characterization of Host Protein Complement of Rift Valley Fever Virus Virions and Identification of Specific Heat Shock Proteins, Including HSP90, as Important Viral Host Factors

Jonathan E. Nuss, Kylene Kehn‐Hall, Ashwini Benedict et al. · PLoS ONE · 2014 · 30 citations · Full text

Life Sciences, Infectious Diseases, Molecular Biology +17

Development of Cell-Based Assays to Measure Botulinum Neurotoxin Serotype A Activity Using Cleavage-Sensitive Antibodies

Jonathan E. Nuss, Gordon Ruthel, Lyal E. Tressler et al. · SLAS DISCOVERY · 2009 · 28 citations · Full text

Life Sciences, Neurobiology, Neuroscience +16

Post-Intoxication Inhibition of Botulinum Neurotoxin Serotype A within Neurons by Small-Molecule, Non-Peptidic Inhibitors

Gordon Ruthel, James C. Burnett, Jonathan E. Nuss et al. · Toxins · 2011 · 27 citations · Full text

Medicine, Neurobiology, Neuroscience +14